These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12544443)

  • 1. Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats.
    Millette E; de Champlain J; Lamontagne D
    J Hypertens; 2003 Jan; 21(1):115-23. PubMed ID: 12544443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension.
    Millette E; de Champlain J; Lamontagne D
    J Hypertens; 2000 Dec; 18(12):1783-93. PubMed ID: 11132602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats.
    Zhao H; Joshua IG; Porter JP
    Am J Hypertens; 2000 Jul; 13(7):819-26. PubMed ID: 10933575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 2000 Jul; 400(2-3):231-7. PubMed ID: 10988339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
    Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
    J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD; He G; Schiffrin EL
    Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats.
    Kita S; Taguchi Y; Chatani S; Matsumura Y
    Eur J Pharmacol; 1998 Feb; 344(1):53-7. PubMed ID: 9570448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
    Sharifi AM; Schiffrin EL
    J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
    Giulumian AD; Molero MM; Reddy VB; Pollock JS; Pollock DM; Fuchs LC
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1944-9. PubMed ID: 11959662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.
    Florian JA; Watts SW
    Am J Physiol; 1999 Mar; 276(3):H976-83. PubMed ID: 10070082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS; Larivière R; Schiffrin EL
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.